Daily Archives: February 28, 2022

Webcast Presentation – Masitinib filing in the treatment of ALS in Canada and update on AB Science clinical program in all indications

28/02/2022 – Presentation of the webcast held on February 28, 2022 on masitinib filing in the treatment of ALS in Canada and update on AB Science clinical program in all indications

Financing of a 8.5 million dollars through the issuance of convertible bonds with attached warrants

28/02/2022 – AB Science announces today that it reached an agreement with a historical investor on a financing of USD 8.5 million through the issuance of bonds convertible into new ordinary shares with attached warrants